Chargement en cours...
Intravenous zoledronate for osteoporosis: less might be more
Annual administration of 5 mg intravenous zoledronate is moderately effective in reducing fracture risk in older adults, decreasing the relative risk of clinical fracture by 33%. However, almost 10 years after its approval for use in clinical practice there remain very substantial uncertainties abou...
Enregistré dans:
| Publié dans: | Ther Adv Musculoskelet Dis |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959627/ https://ncbi.nlm.nih.gov/pubmed/27493690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X16650866 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|